Gokmen, A. Et Al. 2022. Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies. Transplantation and Cellular Therapy , vol.28, no.3 , 245.

Gokmen, A., Şahin, U., Soydan, E., Okcu, M. K., Arslan, O., & Özcan, M., (2022). Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies. Transplantation and Cellular Therapy , vol.28, no.3, 245.

Gokmen, Ayla Et Al. "Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies," Transplantation and Cellular Therapy , vol.28, no.3, 245, 2022

Gokmen, Ayla Et Al. "Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies." Transplantation and Cellular Therapy , vol.28, no.3, pp.245, 2022

Gokmen, A. Et Al. (2022) . "Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies." Transplantation and Cellular Therapy , vol.28, no.3, p.245.

@article{article, author={Ayla Gokmen Et Al. }, title={Low Dose TBI in Addition to Low Dose Melphalan and Fludarabine As a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation in Patients with High Risk Hematologic Malignancies}, journal={Transplantation and Cellular Therapy}, year=2022, pages={245} }